882 filings
Page 3 of 45
424B3
i5962y43
21 Aug 23
Prospectus supplement
6:05am
EFFECT
273o8n0
21 Aug 23
Notice of effectiveness
12:15am
CORRESP
xt2zygm59n8q3
16 Aug 23
Correspondence with SEC
12:00am
UPLOAD
wnudfl 14y
16 Aug 23
Letter from SEC
12:00am
8-K
r8gee664
14 Aug 23
Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
4:12pm
4
j0uuytt0le cnnxt
8 Jun 23
PLUS THERAPEUTICS / Howard Clowes ownership change
7:00am
8-K
uet t8u8kvv
16 May 23
Other Events
8:09am
4
n474r0yp7b0lp443zbk
4 May 23
PLUS THERAPEUTICS / Howard Clowes ownership change
7:00am
8-K
xwh1ttha
28 Apr 23
Plus Therapeutics Announces Reverse Stock Split
4:34pm
8-K
f1vgvz0h
21 Apr 23
Submission of Matters to a Vote of Security Holders
6:30am
8-K
5pv22o 2ix
20 Apr 23
Plus Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
ot6iijq c85eqp
13 Mar 23
Regulation FD Disclosure
6:30am
4
fw70eejkjobt
6 Mar 23
PLUS THERAPEUTICS / Richard J Hawkins ownership change
7:40pm
8-K
6wv6r9
3 Mar 23
Entry into a Material Definitive Agreement
4:31pm
8-K
orgfntnmby3 18pi
23 Feb 23
Plus Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
4:10pm